Literature DB >> 19799694

Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009.

Nicholas J Talley1, Rok Seon Choung.   

Abstract

Functional dyspepsia is a highly prevalent but heterogeneous disorder; multiple pathogenetic mechanisms are likely involved but the underlying causal pathways in functional dyspepsia remain obscure. The term functional dyspepsia was popularized by the famed Walter Alvarez at the Mayo Clinic early last century. Prominent Australian gastroenterologists who have contributed to our understanding of functional dyspepsia include Peter Baume, Barry Marshall, Douglas Piper, Nick Talley, John Kellow, and Gerald Holtmann. Specific dyspeptic symptoms have not generally correlated very well with any particular physiologic disturbance, although gastric disaccommodation and duodenal eosinophilia have been linked to early satiety in this condition. Genetic markers have been tentatively identified, and functional dyspepsia can follow bacterial gastroenteritis. No objective diagnostic tools for functional dyspepsia are currently agreed upon, although meal induction of symptoms appears reproducible and may have diagnostic utility. The symptomatic criteria for functional dyspepsia (Rome III criteria) are based on expert consensus and the exclusion of organic causes. Various therapeutic modalities for functional dyspepsia have been explored; however, empirical approaches are still employed for the treatment of functional dyspepsia. Better approaches for functional dyspepsia are likely to follow an improved understanding of the underlying pathophysiological abnormalities.

Entities:  

Mesh:

Year:  2009        PMID: 19799694     DOI: 10.1111/j.1440-1746.2009.06067.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Inhibition of gastric perception of mild distention by omeprazole in volunteers.

Authors:  Akihito Iida; Hiroshi Kaneko; Toshihiro Konagaya; Yasushi Funaki; Kentaro Tokudome; Shinya Izawa; Yasuhiro Tamura; Mari Mizuno; Naotaka Ogasawara; Makoto Sasaki; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

Review 2.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

3.  Current and emerging therapies for the management of functional gastrointestinal disorders.

Authors:  Orla F Craig; Eamonn M M Quigley
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

4.  Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression.

Authors:  Han-Guang Du; Li Ming; Shu-Jiao Chen; Can-Dong Li
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

6.  Dyspepsia in the community: value of a community-based mailed survey to identify potential participants for a randomized clinical trial.

Authors:  Linda M Herrick; Giles Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Vickie Treder; Nicholas J Talley
Journal:  Scand J Gastroenterol       Date:  2015-03-11       Impact factor: 2.423

Review 7.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

8.  Temperature can influence gastric accommodation and sensitivity in functional dyspepsia with epigastric pain syndrome.

Authors:  Rui-Feng Wang; Zhi-Feng Wang; Mei-Yun Ke; Xiu-Cai Fang; Xiao-Hong Sun; Li-Ming Zhu; Jing Zhang
Journal:  Dig Dis Sci       Date:  2012-09-04       Impact factor: 3.199

9.  [Managing of the patient with dyspepsia. Clinical Practice Guideline. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet Calvo; Juan Ferrándiz Santos; Juan José Mascort Roca; Pablo Alonso-Coello; Mercè Marzo Castillejo
Journal:  Aten Primaria       Date:  2012-10-22       Impact factor: 1.137

10.  Modified chaihu shugan powder for functional dyspepsia: meta-analysis for randomized controlled trial.

Authors:  Nan Yang; Xuehua Jiang; Xuelan Qiu; Zhiqiang Hu; Ling Wang; Minxian Song
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.